RECOMBINANT CYTOTOXIN AND USE THEREOF
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
N/A
Issued Date -
Jun 1, 2017
app pub date -
Jul 26, 2016
filing date -
Nov 26, 2015
priority date (Note) -
Published
status (Latency Note)
Importance
Calculated Rating
|
US Family Size
|
Non-US Coverage
|
Abstract
A recombinant cytotoxin is provided. The recombinant cytotoxin of the present invention comprises a cytotoxin, a cell penetrating peptide (CPP), and Asp-Glu-Val-Asp (DEVD) sequence inserted in the cytotoxin. The recombinant cytotoxin can induce a targeting cell into the apoptotic pathway and be cleaved by the enzyme generated from apoptotic pathway. The present invention also provides a method for treating cancer, comprising administrating the recombinant cytotoxin to a subject.
First Claim
Other Claims data not available
Family
+
−
| Country | kind | publication No. | Filing Date |
|---|---|---|---|
| TW | B | TWI577694 | Nov 26, 2015 |
International Classification(s)
- 2016 Application Filing Year
- C07K Class
- 6208 Applications Filed
- 4030 Patents Issued To-Date
- 64.92 % Issued To-Date
Cited Art Landscape
Patent Citation Ranking
- 0 Citation Count
- C07K Class
- 0 % this patent is cited more than
- 8 Age